Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer
Position
Chief Commercial Officer
Company
Cognito Therapeutics
CambridgeManufacturingBiotechnologyHealthcareHealth CareMedicalTherapeuticsDescription
Cognito announces the appointment of Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer to enhance its leadership team. These executives bring extensive experience in commercialization, technology, and operations as the company enters a new growth phase.
Quick answer
Cognito Appoints Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer (November 13, 2026). Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Cognito Therapeutics?
- Cognito Therapeutics named Joe Perekupka Chief Commercial Officer, announced November 13, 2026.
- What did Cognito Therapeutics announce on November 13, 2026?
- Cognito announces the appointment of Joe Perekupka as Chief Commercial Officer, Urvashi Tyagi as Chief Technology Officer, and Dave Watson as Chief Operating Officer to enhance its leadership team. These executives bring extensive experience in commercialization, technology, and operations as the company enters a new growth phase.
- Where did Joe Perekupka work before joining Cognito Therapeutics?
- Joe Perekupka joins from Freespira.
- What does Cognito Therapeutics do?
- Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance.
- Where is Cognito Therapeutics based?
- Cognito Therapeutics is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (November 15, 2026), Immuneering (November 9, 2026), AbbVie Inc. (November 2, 2026) and Gyre Therapeutics (October 22, 2026) also announced leadership changes within 45 days of Cognito Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Medical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Cristian Massacesi as Head of R&D (November 15, 2026)
- Grant C. Bogle Appointed as Class III Director at Immuneering Corporation (November 9, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- Absci Corporation Appoints Gerry Muhle as Chief Commercial Officer (November 12, 2026)
Who to call at Cognito Therapeutics, and when
A new leader at Cognito Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cognito Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cognito Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cognito Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cognito Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Cognito Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.